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Self-Management of Chronic Illness: The Role of 'Habit' vs Reflective
Factors in Exercise and Medication Adherence
Abstract
Non-adherence to health behaviors required for chronic illness self-management is pervasive. Advancing
health-behavior theory to include behavioral initiation and maintenance factors, including reflective (e.g.,
belief- and feedback-based) and automatic (e.g., habit-based) mechanisms of adherence to different
treatment-related behaviors could improve non-adherence prediction and intervention efforts. To test
behavioral initiation and maintenance factors from an extended common sense self-regulation theoretical
framework for predicting medication adherence and physical activity among patients with Type 2 diabetes.
Patients (n = 133) in an in-person (n = 80) or online (n = 53) version of the study reported treatment-related
(1) barriers, (2) beliefs and experiential feedback (reflective mechanisms of treatment-initiation and short-
term repetition), and (3) habit strength (automatic mechanism of treatment-maintenance) for taking
medication and engaging in regular physical activity at baseline. Behaviors were assessed via self-reports (n =
133) and objectively (electronic monitoring pill bottles, accelerometers; n = 80) in the subsequent month.
Treatment-specific barriers and habit strength predicted self-reported and objective adherence for both
behaviors. Beliefs were inconsistently related to behavior, even when habits were “weak”. Experiential
feedback from behavior was not related to adherence. Among patients with Type 2 diabetes diagnosis,
medication and physical activity adherence were better predicted by their degree of automatic behavioral
repetition than their beliefs/experiences with the treatment-actions. Habit strength should be an intervention
target for chronic illness self-management; assessing it in practice settings may effectively detect non-
adherence to existing treatment-regimens. However, future research and further refining of CS-SRM theory
regarding the processes required for such habit development are needed.
Keywords
Commonsense self-regulation, Adherence, Exercise, Habit, Type 2 diabetes
Disciplines
Health Psychology | Other Psychology | Pain Management
Comments
This is the SUBMITTED VERSION of an article, a later version of which has been published in the
Journal of Behavioral Medicine (http://link.springer.com/article/10.1007/s10865-016-9732-z).
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/psychology_pubs/42
1 
 
Running Head: HABIT AND TREATMENT ADHERENCE 
 
Self-Management of Chronic Illness: The Role of 'Habit' vs Reflective Factors in Exercise and 
Medication Adherence 
 
L. Alison Phillips1 
Joshua Cohen2 
Edith Burns3 
Jessica Abrams4 
Steffi Renninger4 
1Department of Psychology, Iowa State University 
W112 Lagomarcino Hall, Ames, IA 50011 
Email: alisonp@iastate.edu 
 
2The George Washington University, Medical Faculty Associates, Division of Endocrinology 
3Medical College of Wisconsin, Division of Geriatrics and Gerontology, Department of 
Medicine 
4The George Washington University, Department of Psychology 
 
Funding Statement: This work was funded by a Research Starter Grant in Adherence 
Improvement from the PhRMA Foundation 
 
This is the SUBMITTED VERSION of an article, a later version of which has been 
published in the Journal of Behavioral Medicine 
(http://link.springer.com/article/10.1007/s10865-016-9732-z).  
Habit and Treatment Adherence    2 
 
Abstract 
Background. Non-adherence to health behaviors required for chronic illness self-management is 
pervasive. Advancing health-behavior theory to include behavioral initiation and maintenance 
factors, including reflective (e.g. belief- and feedback-based) and automatic (e.g., habit-based) 
mechanisms of adherence to different treatment-related behaviors could improve non-adherence 
prediction and intervention efforts.  
Purpose. To test behavioral initiation and maintenance factors from an extended Common Sense 
Self-Regulation theoretical framework for predicting medication adherence and physical activity 
among patients with Type 2 Diabetes. 
Method. Patients (n=133) in an in-person (n=80) or online (n=53) version of the study reported 
treatment-related (1) barriers, (2) beliefs and experiential feedback (reflective mechanisms of 
treatment-initiation and short-term repetition), and (3) habit strength (automatic mechanism of 
treatment-maintenance) for taking medication and engaging in regular physical activity at 
baseline. Behaviors were assessed via self-reports (n=133) and objectively (electronic 
monitoring pill bottles, accelerometers; n=80) in the subsequent month. 
Results. Treatment-specific barriers and habit strength predicted self-reported and objective 
adherence for both behaviors. Beliefs were inconsistently related to behavior, even when habits 
were “weak”. Experiential feedback from behavior was not related to adherence.   
Conclusions. Among patients with Type 2 diabetes diagnosis, medication and physical activity 
adherence were better predicted by their degree of automatic behavioral repetition than their 
beliefs/experiences with the treatment-actions. Habit strength should be an intervention target for 
chronic illness self-management; assessing it in practice settings may effectively detect non-
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adherence to existing treatment-regimens. However, future research and further refining of CS-
SRM theory regarding the processes required for such habit development are needed. 
Keywords. Commonsense Self-Regulation; Adherence; Exercise; Habit; Type 2 Diabetes 
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Self-Management of Chronic Illness: The Role of 'Habit' vs Reflective Factors in Exercise and 
Medication Adherence 
Self-management of chronic illness requires long-term (i.e. lifelong), regular engagement 
in multiple treatment-related behaviors, such as taking medications and regular physical activity 
(PA) (García-Pérez et al., 2013). Non-adherence to these behavioral recommendations for 
chronic illness self-management is pervasive and the main cause of poor patient outcomes and 
high healthcare costs (Kravitz & Melnikow, 2004; Van Dulmen et al., 2007). Health behavior 
theories have had success predicting at least some of the variance in non-adherence to 
medications and regular physical activity (e.g., Health Belief Model, Rosenstock et al., 1988; 
Theory of Planned Behavior, Ajzen, 1991; Self-Determination Theory, Deci & Ryan, 2000). 
However, interventions based on these theories have had some, but little effect in promoting 
longer-term maintenance of the targeted behaviors (McDonald et al., 2002; Norris et al., 2001). 
To advance the predictive utility of these theories, and therefore, the effectiveness of 
interventions, more work is required in theory development (Rothman, 2004; Phillips et al., 
2012) and in evaluation of theory in multiple behavioral and illness contexts (Creer & Holroyd, 
1997; Elwood, 2015). Integrated theoretical frameworks that cover factors involved in both 
behavioral initiation and maintenance are required to understand, predict, and promote long-term 
behavior change (Phillips et al., 2013; Rothman, 2004; Rothman et al., 2009). Health behavior 
theories primarily focus on reflective (i.e. consciously processed, deliberative), initiation factors 
(e.g., social cognitive theories of health behavior; Bandura, 2001); maintenance of behavior is an 
assumed outcome of successful initiation. For example, if individuals hold favorable beliefs 
about a behavior and have self-efficacy for performing the behavior, they will intend to engage 
in the behavior, initiate behavior, and repeat behavior (Ajzen, 1991). However, two areas of 
Habit and Treatment Adherence    5 
 
research have shown that initiation factors are not sufficient for explaining long-term behavioral 
engagement: first, maintenance factors differ from initiation factors (Rothman, 2000; Rothman et 
al., 2009). Second, research has shown that behavioral beliefs and intentions are less predictive 
of behavior in the long-term, specifically when individuals have developed strong behavioral 
habits (Danner et al., 2008; Gardner, 2014; but see Rhodes & de Bruijn, 2010). When behavior is 
habitual, it is automatic and not dependent on reflective factors such as intentions and the beliefs 
that contribute to these intentions. Therefore, to more fully explain variance in adherence, 
initiation and maintenance factors should be integrated in theory. 
The Common Sense Self-Regulation Model (CS-SRM; Leventhal et al., 2003; Leventhal 
et al., 2008) has been widely used to understand, predict, and change individuals’ self-
management practices and outcomes. The current study extends this theory to include behavioral 
maintenance factors, namely habit strength, which is an automatic mechanism of behavioral 
repetition. Below, we first explain the extended CS-SRM framework and how its constructs may 
function differently for different illness contexts; we then describe the current study, the purpose 
of which is to empirically test key elements of the extended CS-SRM for predicting adherence to 
two specific treatment-related behaviors—taking medication and engaging in regular physical 
activity. Both are important behaviors for successful self-management of many chronic 
conditions, including the current study population of patients with Type 2 diabetes (DiMatteo et 
al., 2002; García-Pérez et al., 2013). 
Extending the Common Sense Self-Regulation Model (CS-SRM) 
The CS-SRM is a theoretical framework that describes the primarily reflective, or 
deliberative processes by which individuals formulate illness- and treatment-related beliefs and 
behavioral action plans for addressing a health-threat (symptom, illness) and/or its emotional 
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consequences. The left side of Figure 1 depicts the processes described in existing accounts of 
the CS-SRM (see Mora & McAndrew, 2013; Scott et al., 2012), in which messages regarding a 
health threat are evaluated and interpreted, leading to an emotional response and formation of an 
illness representation. The illness representation includes beliefs about the threat’s potential 
label/diagnosis and associated symptoms (identity), causes, consequences, control factors, and 
duration/timeline. These beliefs influence an individuals’ perceived possible treatment-related 
actions, including seeking care, self-treatment, or other action(s). The illness- and treatment-
representations (beliefs about the necessity and consequences of the specific treatment-action; 
Horne et al., 1999) are theorized to lead to action-planning, initial action, and eventually 
adherence to treatment-related behaviors over time.  
The primary use of the CS-SRM in research and interventions to date has been in 
predicting and/or manipulating patients’ beliefs about their illness and treatment to promote 
better illness coping and treatment adherence. Patients’ illness- and treatment-related beliefs are 
known predictors of medication adherence in many chronic illness domains, including Type 2 
Diabetes (Glasgow et al., 1997; Horne & Weinman, 2002; Mann et al., 2009; Petrie et al., 2007). 
A recent meta-analysis of the relationships between patients’ medication-related necessity beliefs 
and concerns indicated that both types of beliefs are important for long-term treatment adherence 
(Horne et al., 2013). However, reflective initiation factors may not be sufficient for explaining 
variance in long-term treatment adherence, because maintenance factors differ from initiation 
factors, and behavioral habits, when strong, take over prediction of behavior from more 
reflective factors, such as beliefs. In fact, some research has shown beliefs do not predict 
adherence, particularly when adherence is measured objectively (Cooper et al., 2010; Phillips et 
al., 2013). It is possible that beliefs may play a larger role in some illness contexts compared to 
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others; for example, beliefs may be more predictive of adherence in conditions with greater 
treatment side effects or when adherence is more variable overall. They may also play a larger 
role in predicting adherence to other types of treatment behaviors, such as physical activity. 
The CS-SRM posits that individuals’ illness- and treatment-representations lead to action 
plans and action. What is included in existing accounts of the CS-SRM but is not widely 
researched is the role of experiential feedback that patients receive from testing those treatment-
related actions (depicted in the middle part of Figure 1) in changing their representations and in 
contributing to adherence. Gaining feedback through action is theoretically important, because 
feedback can lead to a coherent system (a general understanding of the illness characteristics and 
required treatment(s); Phillips et al., 2013) and behavioral repetition. Without feedback that a 
behavior works as expected, the individual theoretically re-evaluates the health threat’s cause, 
identity, control, timeline, and/or consequences as well as the treatment-action’s necessity and 
consequences. Therefore, this feedback and a coherent system is theoretically required for 
continued behavioral repetition, and therefore longer-term adherence. Research to test this aspect 
of the CS-SRM has been mostly limited to static beliefs regarding the illness in general rather 
than specific treatment-related actions (e.g., from the IPQ-R, Moss-Morris et al., 2002: “I 
understand my illness, not at all to very much”; see also McAndrew et al., 2008). Phillips et al. 
(2013) tested whether patients’ reports of receiving experiential feedback that their medication 
works as expected predicted medication adherence, and found that such experiences predicted 
intentional non-adherence but not overall or objectively measured adherence. This construct has 
not been much studied in a Type 2 Diabetes context, but some researchers have evaluated the 
benefit of behavioral feedback for optimal adherence: Tanenbaum et al. (2015) interviewed 
patients in good control of their Type 2 Diabetes and found that patients used their blood glucose 
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meters as a source for feedback on how their self-management efforts were working. Research in 
the symptom-interpretation literature, which shows that patients use symptom changes to 
evaluate behavioral success, also supports the importance of experiential feedback and belief-
coherence for treatment adherence and illness management (e.g., Siegel et al., 1999). Phillips et 
al. (2013) suggested that experiential feedback may be more important for determining treatment 
adherence in illnesses that are symptomatic and/or for behaviors that can provide feedback 
(unlike with hypertension, where patients cannot tell if their blood pressure is up or is under 
control with medication; Meyer et al., 1985). Reflective factors in general may better predict 
intentional (i.e. skipping a dose, decreasing or increasing a dose) than unintentional non-
adherence (i.e. forgetting; Phillips et al., 2013). 
With a coherent system, it is possible that a person’s action plans may change to 
strategies for behavioral maintenance (Brooks et al., 2015) but remain reflective, or deliberative 
(e.g., satisfaction with continued behavioral outcomes, Fleig et al., 2013). With repetition in 
stable contexts, however, the behavior may shift to automatic repetition through habitual action 
(Rothman et al., 2009). Habitual action does not require reflection or deliberation on the reasons 
for doing a behavior, because habits are automatically triggered by conditioned contextual cues 
(Wood & Neal, 2007; Gardner, 2014; e.g. a person may automatically take his medication after 
brushing his teeth in the AM and PM). The right side of Figure 1 depicts this added construct to 
the existing CS-SRM constructs. Habits are theoretically important for long-term adherence, 
because they do not tax cognitive and self-regulatory resources, are not subject to tempting 
behavioral alternatives, and are the default behavior (Aarts et al., 1997; Danner et al., 2008). 
Indeed, habits are more likely to be maintained than non-habits (Orbell & Verplanken, 2010; 
Phillips et al., 2013), and habit strength has been found to predict behavior in different domains, 
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including dietary behavior (Wiedemann et al., 2014), physical activity (Gardner et al., 2012); and 
medication adherence (Bolman et al., 2011; Phillips et al. 2013). The degree to which behavioral 
habit strength predicts treatment adherence among patients with Type 2 Diabetes has not been 
studied, to our knowledge; further, the relative importance of habit strength for predicting 
medication adherence versus a more complex behavior, such as physical activity, within the 
same population has not been studied in any illness-management or -prevention context. Phillips 
et al. (2013) found that habit strength was the strongest predictor of objective and self-reported 
medication adherence, suggesting interventions should focus on habit development. However, 
they concluded that more research is needed in different illness-contexts, such as those that are 
symptomatic, have greater treatment complexity (requiring more complex medication regimens 
but also different treatment behaviors), and allow for direct experiential feedback from 
treatment-related behaviors. 
The Current Study 
We have outlined above how automatic factors can extend the CS-SRM to explain 
behavioral maintenance, and we have described the process by which an individual may move 
from reflective formation of illness and treatment beliefs to automatic enactment of treatment-
actions (Figure 1). The current study focuses on taking those CS-SRM constructs specific to a 
treatment-related behavior and testing their importance for predicting non-adherence to that 
behavior (i.e. using the theoretical constructs from the extended CS-SRM to predict adherence 
and to evaluate the behavior/treatment-specific and illness-specific roles of these factors for 
predicting adherence). Namely, the current study evaluates the importance of (1) treatment-
related beliefs; (2) experiential feedback that the behavior works as expected; and (3) treatment-
related habit strength for predicting variance in both medication adherence and physical activity. 
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The degree to which the tested theoretical constructs, both reflective and automatic, 
predict treatment adherence (i.e. their relative importance) may depend on the illness-context and 
on the target behavior. The current study focuses on Type 2 Diabetes, which has a very high and 
climbing prevalence and a significant impact on healthcare and patient quality of life (Knowler et 
al., 2002). Type 2 Diabetes presents different characteristics than hypertension in that it can be 
symptomatic, requires daily management with feedback from a monitor, and involves multiple 
treatment behaviors for successful management (García-Pérez et al., 2013). When a condition is 
symptomatic and requires multiple treatment-related behaviors of varying complexity, there may 
be differences in the influence of the theoretical factors on adherence and illness self-
management, which affects our proposed theoretical factors in long-term adherence. First, beliefs 
may be more predictive of treatment adherence when a treatment has greater likelihood of 
negative side effects; compared to hypertension medication, medications for Type 2 Diabetes 
and physical activity have potentially more severe and frequent side effects. Second, the role of 
experience (i.e. experiential feedback) may be more important for management of a symptomatic 
condition, where feedback is possible and frequent. Furthermore, experience (experiential 
feedback) may be more important for a behavior that requires more time and effort (i.e. the 
individual may need to be more convinced through experience to continue that behavior than for 
a simple behavior that has no cognitive or time costs)—specifically exercise versus taking a 
medication. Lastly, the role of habit may depend on the complexity of the treatment-related 
behavior. When a behavior is relatively simple, such as taking one pill once a day, then context 
cues may be sufficient to trigger a habit and maintain adherence in the long-term. For complex 
behaviors, such as physical activity, beliefs and experiential feedback may remain important, 
along with a degree of habit strength, in predicting behavioral maintenance. That is, although the 
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theoretical process for behavior initiation to maintenance may be universal, the factors’ relative 
importance for adherence may differ for different target behaviors. 
Specifically, the study tests the following hypotheses:  
(1) The primary hypothesis is that the two reflective repetition factors (treatment-specific 
beliefs and experiential feedback; behavior-specific factors in the left and middle parts of Figure 
1) and the automatic repetition factor (treatment-specific habit strength, right part of Figure 1) 
will significantly and uniquely predict adherence to medication and regular physical activity.  
(2) Regarding the reflective factors in behavioral initiation and repetition, we hypothesize 
the following: (a) treatment-specific beliefs will more strongly predict adherence when habit 
strength is low vs high (i.e. habit strength will moderate the relationship between beliefs and 
adherence); and (b) treatment-specific beliefs and experiential feedback will predict intentional 
more-so than unintentional non-adherence to medication (R1>R2 in Figure 2a). 
(3) Regarding automatic processes of behavioral repetition, or treatment-specific habit 
strength, we hypothesize the following: (a) medication-related habit strength will more strongly 
predict objectively-measured dose-timing adherence (% of daily doses taken on time, within a 
two-hour window—indicating presence of a stable context cue for action) compared to overall 
adherence (% of days prescribed number of doses were taken; action may be reflective and not 
tied to context cue); and (b) medication-related habit strength will more strongly predict 
unintentional compared to intentional non-adherence to medication (R4>R3 in Figure 2a). 
(4) Lastly, the relative influence of habit strength compared to reflective factors (beliefs 
and experiential feedback) on medication adherence is expected to be greater than that for 
physical activity (i.e. even if habit strength is the strongest predictor for both behaviors in 
absolute terms, its relative importance compared to that of the reflective factors is expected to be 
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greater for medication adherence than for physical activity). In Figure 2b, the difference between 
R7 and R5 is expected to be greater than the difference between R8 and R6. 
Method 
Participants 
Participants in the Washington D.C. sample (n=99) and the Milwaukee, Wisconsin 
sample (n=34) were patients with diagnoses of Type 2 Diabetes recruited from endocrinology 
clinics in their respective cities. The sample-specific demographics are provided in Table 1. In 
the total sample of 133 participants, the average age was 56.96 years (SD = 12.04), the average 
length of time since diagnosis with Type 2 Diabetes was 10.26 years (SD = 12.85), 62% were 
female, 92% identified as Non-Hispanic, 41% identified as Caucasian/White race, 52% identified 
as African/Black race, 7% identified as other minority or multi-racial, 52% had a 4-year college 
degree/equivalent or higher level of education, and 79% had been on their current diabetes 
medication for at least 1 year (with modal duration = 1-3 years on the medication). 
We conducted a power analysis prior to the start of the study to estimate the required 
sample size to detect a small-to-medium effect (by convention; Faul, Erdfelder, Lang, & 
Buchner, 2007) in the R2-change when “experiential feedback” was added as a predictor of 
adherence after treatment-related beliefs and barriers were first entered as predictors, and for the 
R2-change when “habit strength” was added as a final predictor in the hierarchical linear 
regression (these analyses are for the primary hypotheses for the two target behaviors). The 
effect size estimate (f2 = 0.09 or partial R2 = 0.08) came from existing literature that tested 
similar hypotheses (Phillips et al., 2013) in a different illness-context. The power analysis, 
conducted with G*Power (Faul et al., 2007), with power = 0.90, and α = .05 yielded a required 
sample size estimate of 119. Resources limited the number of participants who could complete 
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the in-person version of the study (n=80); an online-only version of the study was used to 
increase the sample size for all analyses except those using objective outcomes (n=133). 
Procedure 
Inclusion criteria were the following: the patient had to (1) have been seen at the clinic 
within the past calendar year (to eliminate patients in the system who were no longer patients at 
the practice), 2) be 18 years of age or older, 3) be on pill-form medication for treatment of Type 
2 Diabetes, and 4) be proficient in speaking English. Patients were identified in the clinics’ 
medical records to meet these criteria; those who met these eligibility criteria were sent letters 
inviting them to participate in the study. They were given the option to call study personnel, to 
provide their contact information in a postage-paid envelope so that the study personnel could 
contact them, or to email study personnel with questions about the study or to indicate their 
interest. Study personnel in Washington D.C. also recruited patients for the study in-person, at 
the endocrinology clinic; eligible patients were first identified by clinic staff and then 
approached by study personnel. The volunteer rate via recruitment letters and in-clinic 
recruitment was approximately 11%. Although low, these response rates are comparable to other 
clinic populations with volunteer samples (Andersen et al., 2010; Phillips et al., 2013). All 
procedures were approved by the relevant institutions’ human ethics committees. 
In-person study version. After indicating interest, patients were scheduled for a 1- to 
1.5- hour baseline appointment at which they filled out the baseline survey on a computer in a 
study office and given an electronic monitoring pill bottle and a Fitbit to use for the subsequent 
month. Participants were compensated with 20 dollars cash at the end of the baseline visit. After 
the month of using the devices, participants self-reported physical activity and medication 
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adherence in the preceding month and mailed back the devices in pre-paid envelopes or returned 
them in person. They were then mailed a check for 30 dollars. 
Online-only study version. After indicating interest, patients were emailed a link to the 
same baseline survey (on Qualtrics.com) that in-person study participants completed. One month 
after completing the baseline survey, participants were sent a second survey link and then mailed 
a check for 25 dollars. 
Measures 
Demographics and information regarding duration of Type 2 Diabetes diagnosis and 
treatment were evaluated along with the following scales. Descriptive statistics, internal 
consistency values, and bivariate correlations between study variables are in Tables 2 and 3. 
Medication adherence barriers. Patients reported barriers to taking medications on the 
Brief Medication Questionnaire (Svarstad et al., 1999); e.g., “My medication causes side effects” 
and “It is hard to pay for the medication”: None (=1), a little (=2), a lot (=3). Seven items were 
averaged to represent the variable, with moderate internal consistency (α=0.61). The low alpha 
may be due to the fact that barriers represent a formative construct, which is not expected to have 
high internal consistency (experience of one type of barrier does not mean other barriers are 
more likely to be experienced; Jarvis et al., 2003); further, relationships between this type of 
construct and other variables is not influenced by measurement reliability error, and so the low 
alpha should not negatively affect the tested relationships. 
Medication-related beliefs. Beliefs were measured using the Specific Necessity Beliefs 
and Specific Concerns subscales of the Beliefs about Medicines Questionnaire (BMQ; Horne et 
al., 1999). Example items are “My health, at present, depends on this medication” and “This 
medication disrupts my life”, respectively; answer options ranged from strongly disagree (=1) to 
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strongly agree (=5). Scores on the variables are averages, with higher values indicating greater 
necessity beliefs and greater concerns about the medication (α=0.85 and 0.82, respectively). 
Experiential feedback from medication. Patients responded to, “Have you noticed the 
positive benefits of the medication? (Yes/No)” and “Have you experienced any solid/convincing 
evidence that the diabetes medication does what it is supposed to do”: No evidence (=1), some 
evidence (=2), solid evidence (=3). The composite variable is an average of the patients’ 
standardized scores on these two items (α=0.76). 
Medication-taking habit strength. Patients reported the degree to which they take their 
medications automatically with the Self-Report Behavioral Automaticity Index (SRBAI; Gardner 
et al., 2012), which is a widely used subscale of the Self-Report Habit Index (Verplanken & 
Orbell, 2003). An example item is, “Taking this medication is something I do automatically”: 
strongly disagree (=1) to strongly agree (=5). The variable is an average of 4 items (α=0.84). 
Physical activity (PA) adherence barriers. Patients self-reported barriers to regular PA 
on the 9 barriers items of the Exercise Benefits/Barriers Scale (Sechrist et al., 1985; e.g., 
“Exercising takes too much of my time” and “It costs too much money to exercise”). Answers 
ranged from strongly disagree (=1) to strongly agree (=5), and items were averaged (α=0.88). 
PA-related beliefs. Items were adapted for measuring patient beliefs in the necessity of 
and concerns with physical activity as a treatment for diabetes. Since this is a novel use of the 
scales that have been evaluated only in a medication-adherence context, we list all the items used 
to measure PA-related beliefs here, all from strongly disagree (=1) to strongly agree (=5). 
Necessity beliefs: “My health, at present, depends on my getting exercise,” “My life would be 
impossible if I did not exercise,” “Without getting exercise I would be very ill,” “My health in 
the future will depend on my getting exercise”, “Exercising protects me from becoming worse” 
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(α =0.81). Concerns: “Having to exercise worries me”, “I worry that exercising is actually bad 
for me,” “Having to exercise disrupts my life”, “I worry that I might get injured when I 
exercise”, and “The reasons for exercising are a mystery to me” (α=0.75). 
Experiential feedback from PA. The same two items were used as for experiential 
feedback from medication, but with “exercise” substituted for “medication” (α=0.66). 
PA-related habit strength. The SRBAI was used as for medication-taking habit strength 
but with the item stem, “Exercising is something I do…” (4 items; α=0.95). 
Medication adherence. Patients self-reported total adherence, intentional non-adherence 
and unintentional non-adherence at one-month follow-up using the Medication Adherence 
Report Scale (MARS; Horne, 2004). Unintentional non-adherence was assessed with the item, “I 
forget to take my medication”: Never (=1) to always (=5). Intentional non-adherence was 
assessed with the average of four items such as “I decide to miss out on a dose”: Never (=1) to 
always (=5). The total adherence scale is an average of the five items, scored so that higher 
values indicate greater adherence (α=0.85). 
For a subset of participants, electronic monitoring pill bottles (Medication Event 
Monitoring System, MEMS, MWV/Aardex Corp) captured the % of days (out of 30) that the 
patient took the prescribed number of doses (one or two) and the % of doses taken “on time”, or 
within a two-hour window determined by the time they took their medication most of the time or 
by the time they were told to take the medication by their provider (if applicable). 
PA frequency. Physical activity was self-reported at follow-up as the number of PA 
sessions in the previous week (PA defined as 30 minutes moderate to vigorous intensity activity 
throughout the day, in at least 10 minute “bouts”). For a subset of the participants, “Fitbit” 
(accelerometer) measurement of average steps per day during the month of study was used. The 
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only missing data in the study was a result of participants forgetting to wear their Fitbit on a 
particular day. All participants wore their Fitbits (verified via software, Fitabase, Fitabase.com) 
on at least 75% of the applicable days, and so an average number of daily steps was calculated to 
represent the variable, from available days, for all participants.  
Analysis Overview 
Before conducting the analyses to test the hypotheses, the data was evaluated for range of 
adherence to both medications and regular physical activity, to detect outliers and potentially 
influential control variables, to assess the construct validity of the predictors in the current 
sample, and to evaluate assumptions of regression analyses.  
To analyze Hypothesis 1 regarding the predictive utility of each theoretical factor in 
adherence, we conducted hierarchical linear regression with treatment-specific barriers, beliefs, 
experiential feedback, and habit strength entered as predictors in separate steps of the model. 
Four regressions were run in total, one for each of the separate outcomes: self-reported and 
objective measures of both medication adherence and physical activity.  
To analyze Hypothesis 2a, regarding the predictive utility of treatment-specific beliefs in 
adherence when habit strength is low vs high, we conducted hierarchical linear regression with 
the interaction between beliefs and habit strength predicting each adherence outcome 
incrementally to the mean-centered, behavior-specific beliefs and habit strength terms, separately 
for medication and physical activity.  
To analyze Hypotheses 2b, 3a, and 3b, which all regard the relative strength of 
relationships between the theorized predictors and different adherence outcomes (e.g., intentional 
versus unintentional), we used correlated-correlation analyses (Meng et al., 1992), also known as 
Steiger’s Z-test. This test is like Fisher’s Z test for comparing the difference between two 
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correlation coefficients but recognizing that the two correlations are not independent of each 
other (they are themselves correlated). In order to calculate a correlation between the reflective 
factors and adherence and compare it to the correlation between habit strength and adherence, we 
determined the multiple R for the two reflective factors (beliefs and experiential feedback; see 
Figures 2a and 2b).  
Lastly, Hypothesis 4, regarding the relative importance of automatic and reflective 
factors for medication adherence versus PA adherence was tested by comparing the 95% 
confidence intervals for the difference in adjusted R for habit strength and reflective factors in 
predicting medication adherence compared to PA. That is, adjusted R was determined for each 
relationship shown in Figure 2b, and Steiger’s Z test was then used to determine the 95% CI of 
the difference between R7 and R5 and between R8 and R6. The 95% CI for R7-R5 was then 
compared to the 95% CI for R8-R6 to see if R7-R5 > R8-R6. 
Results 
Preliminary Analyses 
Study correlations and descriptive statistics are reported in Tables 2 and 3. Mahalanobis 
distances did not indicate the presence of any substantial multivariate outliers. Standardized 
residual plots verified normality assumptions except for one analysis, for which one individual 
had a standardized residual value of -7.68; further inspection of univariate outliers indicated this 
patient, a participant in the online version of the study, was an outlier on self-reported 
medication adherence (MARS; standardized score of -5.95) and so was excluded from relevant 
analyses. No other univariate outliers (defined as |Z| > 3.0) were detected.  
Medication- and diagnosis- duration were unrelated to the adherence outcomes. Age was 
significantly related to self-reported total medication adherence (r(130)=0.29, p=0.001) and 
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marginally related to MEMS-measured adherence (%days adherent; r(79)=0.21, p=0.06). Gender 
was significantly related to self-reported PA frequency (r(127)=-0.28, p=0.001) and marginally 
related to Fitbit daily steps (r(75)=-0.22, p=0.06), with women engaging in physical activity 
more than men. Education level was significantly related to patients’ self-reported medication 
adherence (r(128)=0.18, p=0.04), self-reported PA frequency (r(127)=0.26, p=0.003), and Fitbit 
daily steps (r(74)=0.25, p=0.03). Hispanic ethnicity was significantly related to self-reported 
medication adherence (r(123)=0.20, p=0.03). Lastly, minority race status was significantly 
related to self-reported medication adherence (r(130)=-0.26, p=0.003) and MEMS-measured 
adherence (r(79)=-0.29, p=0.009). Results of the multivariate tests, below, are provided with and 
without these control variables included in analyses. 
Regarding bivariate relationships between the theoretical predictors: medication-related 
experiential feedback was significantly related to participants’ necessity beliefs and concerns 
regarding the medication (r(131)=0.37, p<0.001, and r(131)=-0.25, p<0.01, respectively). 
Medication-taking habit strength was only related to medication-related barriers (r(131)=-0.21, 
p<0.05). PA-related experiential feedback was significantly related to participants’ necessity 
beliefs and concerns regarding PA (r(132)=0.36, p<0.001, and r(132)=-0.23, p<0.01, 
respectively). PA-related habit strength was related to PA barriers (r(132)=-0.40, p<0.001); to 
necessity beliefs and concerns regarding PA (r(132)=0.37, p<0.001, and r(132)=-0.33, p<0.001, 
respectively); and to PA-related experiential feedback (r(132)=0.27, p<0.01). These relationships 
provide support for the construct validity of the measures—i.e., that they are capturing the 
constructs intended, in the current sample.  
Tests of the Hypotheses 
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Hypothesis 1. The hypothesis that treatment-specific beliefs, experiential feedback, and 
habit strength would each predict significant, incremental variance in adherence for both 
medication and physical activity was partially supported. First, regarding predictive validity of 
the treatment-specific beliefs: counter to expectations, the medication-specific necessity beliefs 
were not predictive of self-reported or objective medication adherence. Medication-specific 
concerns were only predictive of self-reported total medication adherence (MARS; in the final 
model, specific concerns B=10.09, SE B=0.04, β =-0.17, p<0.05) but not when demographic 
control variables were included. Further, concerns about medication were not related to objective 
medication adherence. The relationship between physical-activity-related beliefs and adherence 
depended on the type of belief and the outcome: Participants’ specific necessity beliefs regarding 
physical activity (PA) predicted self-reported PA frequency incrementally to PA-related barriers: 
in the model with only PA-related barriers and the beliefs constructs as predictors, specific 
necessity beliefs had B=0.65, SE B=0.24, β =0.23, p<0.01. This effect was marginally significant 
in the final model and significant in the final model if control variables (gender and education) 
were included (see Table 6). However, specific necessity beliefs did not predict Fitbit daily steps, 
but specific concerns regarding PA did, with and without control variables (in the final model 
without control variables, B=-1733.50, SE B=644.10, β =-0.36, p<0.01).  
Second, regarding the role of experiential feedback in determining long-term adherence, 
the results were counter to our expectations: experiential feedback that the treatment worked as 
expected was not predictive of any adherence outcome for either target behavior, regardless of 
inclusion of the demographic control variables. 
Third, regarding treatment-specific habit strength, results supported the hypothesis. Habit 
strength consistently predicted incremental variance in the measured outcomes, both self-
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reported and objectively measured, for both target behaviors: Medication-taking habit strength 
predicted significant incremental variance in self-reported total medication adherence (MARS); 
in the final model, B=0.15, SE B=0.04, β =0.32, p<0.001. PA-related habit strength significantly 
predicted self-reported PA frequency in the final model with and without control variables 
included in the analysis (see Table 6; in the final model without control variables, habit strength 
had B=0.66, SE B=0.17, β =0.35, p<0.001). PA-related habit strength significantly predicted 
Fitbit daily steps in the final model, with and without control variables included. 
Regarding barriers, medication-related barriers significantly predicted self-reported total 
medication adherence (MARS) in all steps of the regression (in the final model, B=-0.45, SE 
B=0.13, β =-0.27, p<0.01; see Table 4). When control variables (age, racial minority status, 
ethnicity, and education level) are included in a step prior to medication-related barriers, barriers 
are no longer significantly predictive of MEMS-measured adherence. PA-related barriers 
significantly predicted self-reported PA frequency in all steps of the regression (in the final 
model, PA-related barriers had B=-0.62, SE B=0.29, β =-0.21, p<0.05; with control variables in 
the regression, B=-0.54, SE B=0.28, β =-0.18, p<0.05). PA-related barriers was a significant 
predictor of Fitbit daily steps in the final model, with control variables included (without control 
variables, PA-related barriers was marginally predictive of the outcome; see Table 7).  
Hypotheses 2a and 2b, regarding reflective behavioral factors. Hypothesis 2a, 
regarding the particular importance of treatment-specific beliefs for predicting adherence when 
treatment habit strength was low compared to high was not supported for either target behavior, 
for either type of belief (necessity or concerns): A test of the interaction of patients’ specific 
necessity beliefs for medication and medication-taking habit strength was not significant in 
predicting self-reported medication adherence (MARS) at follow-up (interaction term: B=-0.01, 
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SE B=0.05, β=-0.02, p=0.84) or MEMS-measured adherence (interaction term: B=3.776, SE 
B=4.09, β=0.10, p=0.36). Likewise, the interaction between patients’ specific concerns regarding 
medication and medication-taking habit strength was not significant in predicting self-reported 
medication adherence (MARS) at follow-up (interaction term: B=0.05, SE B=0.05, β=0.09, 
p=0.29) or MEMS-measured adherence (interaction term: B=0.83, SE B=3.27, β=0.03, p=0.80). 
A test of the interaction of patients’ specific necessity beliefs for PA and PA-related habit 
strength was not significant in predicting self-reported PA frequency at follow-up (interaction 
term: B=-0.16, SE B=0.21, β=-0.07, p=0.44) or Fitbit-daily-steps (interaction term: B=-380.54, 
SE B=469.39, β=-0.10, p=0.42). Likewise the interaction between patients’ specific concerns 
regarding PA and PA-related habit strength was not significant in predicting self-reported PA 
(interaction term: B=0.09, SE B=0.21, β=0.03, p=0.67) or Fitbit-daily-steps (interaction term: 
B=-128.56, SE B=397.59, β=-0.04, p=0.75). Including control variables did not alter the results. 
Hypothesis 2b, regarding the role of reflective factors in predicting intentional vs 
unintentional non-adherence to medication was supported: the multiple adjusted R for the 
reflective variables (beliefs and experiential feedback) predicting intentional non-adherence 
(R1=0.23) was significantly greater than the adjusted R for the reflective variables predicting 
unintentional non-adherence (R2=0.06). With intentional and unintentional non-adherence 
correlating with each other at r(130)=0.54, the Z-statistic=2.0 for the difference between R1 and 
R2; this corresponds to a 95% confidence interval for R1-R2=(0.003, 0.34). Reflective factors 
were more predictive of intentional than unintentional non-adherence to medication.   
Hypotheses 3a and 3b, regarding automatic behavioral repetition (habit strength). 
The hypothesis that patients’ medication-taking habit strength would more strongly predict 
MEMS-measured % of doses taken on time than MEMS-measured % of days adherence 
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(prescribed doses taken at any time during the day) was not supported. The correlation between 
habit strength and % doses on time (r(79)=0.40) was not significantly greater than the correlation 
between habit strength and % days adherence (r(79)=0.37). The two MEMS measures correlated 
at r(79)=0.81; the Z-statistic was -0.51 for the difference between their correlations with habit 
strength, which corresponds to a 95% confidence interval=(-0.19,0.11). 
Further, the hypothesis that habit strength would more strongly predict unintentional non-
adherence than intentional non-adherence was not supported: the multiple adjusted R for habit 
strength predicting unintentional non-adherence (R4=0.40) was not significantly greater than the 
adjusted R for habit strength predicting intentional non-adherence (R3=0.33). Intentional and 
unintentional non-adherence correlated at r(130) = 0.54; the Z-statistic was 0.95 for the 
difference between R4 and R3, corresponding to a 95% confidence interval for R4-R3=(-0.09, 
0.26). Habit strength was equally predictive of intentional as unintentional non-adherence. 
Hypothesis 4, regarding the relative role of reflective and automatic factors for 
medication adherence versus PA. The hypothesis that habit strength would be relatively more 
important for predicting medication adherence than PA, compared to reflective factors, was not 
supported: The adjusted R values in Figure 2b for self-reported outcomes were the following: 
R5=0.21, R6=0.33, R7=0.40, and R8=0.44. The adjusted R values in Figure 2b for objective 
outcomes were the following: R5=0.10, R6=0.28, R7=0.36, and R8=0.29. The hypothesis was that 
R7-R5 (= 0.18 for self-reported outcomes and 0.27 for objective outcomes) would be significantly 
greater than R8-R6 (= 0.11 for self-reported outcomes and 0.01 for objective outcomes). 
Although the actual values indicate support for the hypothesis (0.18 > 0.11 and 0.27 > 0.01), the 
95% confidence intervals for all four differences included 0, meaning the confidence intervals 
for R7-R5 and R8-R6 overlapped for both self-reported and objective outcomes. These results 
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indicate that the relative importance of automatic and reflective factors for treatment adherence 
are the same for both types of behaviors. 
Discussion 
The CS-SRM describes how an individual determines a course of action for handling a 
health-related threat. The extended CS-SRM, as depicted in Figure 1, describes how treatment-
related actions may be repeated through reflective means (i.e. because an individual has 
experienced that the behavior meets expectations and his/her beliefs are that the behavior has 
more advantages than disadvantages, etc) or may be repeated through automatic processes, 
through habitual action or response to conditioned cues. Adherence levels in a group of 
individuals are therefore multi-determined; some may be adherent because they intend to adhere 
due to their beliefs in the necessity of the treatment, and some may be adherent because they 
engage in the treatment without thinking (automatically). Treatment repetition may be 
determined by reflective factors, if not habitual, or may be habitual, if not reflective. Therefore, 
in predicting adherence overall, we expected each of the reflective and automatic factors of 
behavioral repetition to be significant predictors of adherence to both medication and physical 
activity (PA) (Hypothesis 1). We also evaluated potential behavior-specific and illness-specific 
roles of these factors in adherence, in tests of Hypotheses 2-4. 
In the test of this primary hypothesis (i.e. that the three measured constructs would 
predict unique variance in patient adherence to medication and PA), only behavior-specific habit 
strength was a consistently significant predictor of self-reported and objective adherence 
measures of behavior, with and without control variables included in the analyses. Beliefs were 
inconsistently related to adherence, and relationships depended on the measure (self-reported or 
objective), whether control variables were included, and the target behavior: specific medication 
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concerns predicted only self-reported medication adherence, and only when control variables 
were not included in the model. Moreover, specific PA-concerns predicted only objective PA, 
and not self-reported PA frequency, whereas specific PA necessity beliefs predicted only self-
reported but not objective PA. As depicted in the left side of Figure 1, when behavior is not 
strongly habitual and therefore is more reflective, behavioral repetition (adherence) should be 
determined at least partially by patients’ beliefs. CS-SRM theory and prior evidence suggest that 
this is so, but the current results match those of Phillips et al. (2013) who found that beliefs did 
not significantly predict adherence, even when behavior was weakly/not habitual. Results from 
the tests of Hypothesis 2a in the current study also suggest that reflective factors are not more 
important when habit strength is low. These results are not in line with existing research 
regarding the interaction of behavioral intentions and habit strength for predicting future 
behavioral engagement (Gardner, 2014). The current results do not mean that patients’ beliefs 
about their medications and PA are unimportant factors in adherence; beliefs at least predicted 
intentional non-adherence. Further, two limitations may have influenced the strength of observed 
relationships between the reflective factors and adherence: the range of adherence may have 
been restricted in the current sample of volunteers and the duration of treatment may have been 
too long to pick up “behavior initiation and initial repetition” processes. 
Regarding the role of experiential feedback for predicting behavior, patients’ reported 
experiences of treatment/behavior effectiveness did not predict treatment-related behavior in the 
current sample of patients with Type 2 Diabetes, despite expectations that they would. While this 
might call into question the validity of the measures for experiential feedback, the psychometric 
assessment of these measures in the current study suggested that they were at least related as 
expected to the other predictor variables (beliefs and habit strength). Existing literature (Phillips 
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et al., 2013) has suggested that experiential feedback may be more likely to influence treatment 
adherence in symptomatic conditions/treatments than in illness contexts where little experiential 
feedback is possible (asymptomatic illness and/or treatments without noticeable side effects of 
benefits). The current study indicates that experiential feedback is no more predictive of 
adherence in patients with Type 2 Diabetes than in patients with hypertension.  
It is possible that beliefs and experiences play a more important role when patients are 
just beginning a new treatment, and habit strength takes over the self-management system rather 
quickly with behavioral repetition. While the current sample had a greater range of medication 
duration than observed in the Phillips et al. (2013) sample, the modal duration was still 1-3 years, 
which may be beyond the time when beliefs are most important for adherence. Counter to 
previous literature (Phillips et al., 2013) and expectations, habit strength equally predicted 
medication dose-timing (% doses taken on time) as % of days adherence to the number of doses 
(i.e. regardless of time taken); and, habit strength equally predicted intentional and unintentional 
non-adherence. Lastly, habit strength and reflective factors were not differentially important for 
PA compared to medication adherence, indicating behavioral complexity may not influence the 
degree to which behavioral maintenance is determined by automatic factors. 
Potential limitations of the current study include the following: first, the validity of self-
reported habit strength has been called into question (Hagger et al., 2014), since automatic 
behaviors are difficult to reflect on and report accurately. However, others have shown that 
participant-reported behavioral automaticity predicts behavioral frequency and maintenance 
incrementally to past behavioral frequency (Orbell & Verplanken, 2010), indicating the measure 
captures the unique aspects of behavioral automaticity from behavioral frequency. Further, since 
the same measure has been used in different published studies, the results of these studies are 
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still comparable to each other and therefore of use to researchers and practitioners. Future 
research should evaluate the basic theoretical role of self-reported behavioral automaticity in 
actual behavioral automaticity in addition to future research designed to develop interventions to 
promote “habit”, or whatever is captured by self-reports of behavioral automaticity—since the 
predictive capability of these reports are garnering strong evidence. Second, although there was 
variability in patients’ adherence to medications and engagement in PA, at a rate comparable to 
other published literature (Andersen et al., 2010; Phillips et al., 2013), those who volunteered for 
the study were likely more adherent than those who did not respond to the recruitment letters. 
Recruiting an inception sample would allow for a better, longitudinal assessment of the 
theoretical factors in determining long-term adherence, capturing those who quit treatment early 
or vary in adherence over time. Lastly, although acceptable for a two-item measure, the low 
internal consistency of the experiential feedback items suggests further measure development is 
required. The relatively low reliability may have prevented the detection of true relationships. 
The current study, along with existing evidence in a hypertension context (Phillips et al., 
2013) indicates that the added habit-strength construct to the CS-SRM theoretical framework is a 
useful addition for predicting behavioral maintenance to multiple types of treatment behaviors 
and in varied illness contexts—simple and complex treatments as well as asymptomatic and 
symptomatic conditions. Researchers could evaluate this extended CS-SRM and the relative 
importance of reflective and automatic behavioral repetition factors in predicting adherence to 
different (and multiple) treatments in different illness contexts. This would allow us to further 
evaluate the usefulness and accuracy of the extended CS-SRM for explaining self-management 
of chronic conditions that vary in severity of consequences, experience of symptoms, availability 
of monitor-based and symptom-based feedback, and complexity of treatment-regimen.  
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Although the current study evaluated single treatment actions, more complex 
management systems are possible and fit within the CS-SRM. For example, future research 
could evaluate sets of management actions that a patient uses to manage an illness. The analyses 
would test the importance of the theoretical constructs for overall management rather than 
adherence to one treatment-related behavior in isolation. Comorbid chronic conditions also 
would influence how an individual maintains his/her health overall. And behavioral maintenance 
through habitual action could be a complex system of context-cues being determined by patients’ 
regular management routines; for example, the successful manager of Type 2 diabetes could 
have a habit of checking his/her blood glucose at key times during the day and respond relatively 
automatically with one treatment action from a “toolbox” of treatment actions, based on prior 
experiential feedback regarding which action works best in specific contexts.  
Possible ramifications of the current research findings for practice are twofold: first, 
practitioners may be able to ask patients about their treatment-related habit strength in order to 
get a good sense of their adherence to existing medications/PA. Second, researchers could test 
the relative effectiveness of behavioral interventions to promote long-term adherence by 
focusing on habit development instead of, or in addition to, interventions that focus on beliefs 
and experiential feedback. While unfavorable beliefs may hinder adherence to treatment 
behaviors, the current study indicates that interventions may be better suited to focus on the 
routinization of treatment behavior and the removal of structural barriers for promoting long-
term PA and medication adherence. Medical providers or close supportive others could 
potentially play a role in implementing interventions to reduce barriers and to promote 
routinization (Nagelkerk et al., 2006; Williams et al., 2004). 
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Figure 1 
Figure 1 illustrates the Common Sense Self-Regulation Model, extended to (1) specify the role of experiential feedback from 
treatment-related action in continued repetition of the behavior and (2) include automatic behavioral repetition, or behavioral habit 
strength, as a treatment adherence factor important for long-term maintenance of treatment-related behavior. 
 
 
38 
 
Figure 2 
Figure 2 illustrates the theoretical hypotheses regarding the relative role of reflective and 
automatic behavioral repetition factors for determining different types of treatment-related 
adherence. 
a.  
 
b.  
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Table 1 
Demographic Information for Separate Samples.  
  Washington DC In‐Person 
Sample 
Washington DC Online 
Sample 
Milwaukee Wisconsin 
Sample (Online) 
Sample Size  81  18  34 
Female  64%  50%  61% 
Hispanic Ethnicity  4%  0%  0% 
Caucasian Race, Non‐Hispanic  26%  31%  82% 
African Race, Non‐Hispanic  68%  56%  15% 
Other or Multiple Racial Identity  6%  13%  3% 
College Education/Equivalent or Higher Education  52%  50%  53% 
Age  57.77 years (SD = 10.86)  54.72 years (SD = 14.72)  56.24 years (SD = 13.31) 
% With Medication Prescription for ≥ 1 Year  87%  50%  62% 
Modal Prescription Duration  1‐3 years  6 months – 1 year  1‐3 years 
Average # Years Diagnosed with Type II Diabetes  10.42 years (SD = 8.39)  11.06 years (SD = 8.86)  9.47 years (SD = 21.04) 
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Table 2 
Medication Adherence Variables: Descriptive statistics, bivariate correlations between variables, and internal consistency alphas (in italics). 
    M(SD) 1 2 3 4  5 6 7 8 9
1.  Barriers to medication adherence (T1) 1.21 (.25) .61  
2.  Medication‐related necessity beliefs (T1) 3.48 (.78) ‐.10 .85  
3.  Medication‐related concerns (T1)  2.54 (.83) .23** ‐.11 .82  
4.  Medication‐related experiential feedback (T1) 0 (.90) ‐.06 .37** ‐.25**  .76
5.  Medication‐taking habit strength (T1) 3.75 (.87) ‐.21* .14 ‐.12  .14 .84
6.  Self‐reported total medication adherence 
(MARS) (T2) 
4.66 (.62) ‐.37† ‐.05 ‐.19*  .03 .40† .85
7.  Self‐reported intentional non‐adherence (T2) 1.24 (.60) .38† ‐.01 .15 .00 ‐.34† ‐.95† .87
8.  Self‐reported unintentional non‐adherence 
(T2) 
1.76 (1.00) .28** ‐.04 .19*  ‐.07 ‐.41† ‐.77† .54† ‐‐
9.  % Days adherent to medication (MEMS) 76.19 (24.3) ‐.28* ‐.06 ‐.17  .13 .37† .53† ‐.44† ‐.50† ‐‐
10.  % Doses taken on time (MEMS)  60.68 (32.0) ‐.27* ‐.12 ‐.25*  .20 .40† .48† ‐.44† ‐.39† .81†
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Table 3 
Physical Activity Variables: Descriptive statistics, bivariate correlations between variables, and internal consistency alphas (in italics). 
    M(SD) 1  2  3  4  5  6 
1.  Barriers to PA (T1)  2.30 (.72)  .88           
2.  PA‐related necessity beliefs (T1)  3.62 (.77)  ‐.30†  .81         
3.  PA‐related concerns (T1)  2.06 (.68)  .54†  ‐.29†  .75       
4.  PA‐related experiential feedback (T1)  0 (.87)  ‐.24**  .36†  ‐.23**  .66     
5.  PA‐related habit strength (T1)  2.54 (1.15)  ‐.40†  .37†  ‐.33†  .27**  .95   
6.  Self‐reported PA frequency (T2)  3.07 (2.18)  ‐.38†  .31†  ‐.26**  .12  .47†  ‐‐ 
7.  Average daily steps (Fitbit)  4665.38 (3285.61)  ‐.08  .13  ‐.33**  .17  .32**  .38† 
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Table 4 
Variables Predicting Self‐Reported Total Medication Adherence (MARS) at Follow‐Up (n=132; n=124 in the final column, with control variables). 
  Model 1  Model 2  Model 3  Model 4 
Model 4 with Control 
Variables 
Variable  B  SE B  β B SE B β B SE B Β  B SE B β B SE B β
Barriers to medication 
adherence  ‐.61  .14  ‐.37†  ‐.55  .14  ‐.33†  ‐.55  .14  ‐.33†  ‐.45  .13  ‐.27**  ‐.39  .14  ‐.23** 
Medication‐related 
necessity beliefs        ‐.02  .04  ‐.03  ‐.01  .05  ‐.02  ‐.03  .04  ‐.05  ‐.03  .05  ‐.05 
Medication‐related 
concerns        ‐.09  .04  ‐.19*  ‐.10  .04  ‐.19*  ‐.09  .04  ‐.17*  ‐.04  .04  ‐.09 
Medication‐related 
experiential feedback              ‐.01  .04  ‐.03  ‐.03  .04  ‐.05  .01  .04  .01 
Medication‐taking habit 
strength                    .15  .04  .32†  .15  .04  .32† 
R2‐Change  .14  .03 .001 .09 .09
F Change  20.35†  2.47  .10  15.69† 16.22†
Note. *indicates regression coefficient is significantly different from 0 at p<0.05; **indicates p<0.01; †indicates p<0.001. 
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Table 5 
Variables Predicting MEMS‐Measured Percentage of Days Adherent to Prescribed Doses (n=80; n=74 in the final column, with control variables). 
  Model 1  Model 2  Model 3  Model 4 
Model 4 with Control 
Variables 
Variable  B  SE B  β B SE B Β B SE B  Β B SE B β B SE B β
Barriers to medication 
adherence  ‐26.38  10.34  ‐.28*  ‐24.25  10.84  ‐.26*  ‐23.99  10.86  ‐.25*  ‐21.00  10.37  ‐.22*  ‐17.93  11.46  ‐.18 
Medication‐related 
necessity beliefs        ‐2.73  3.20  ‐.09  ‐3.40  3.29  ‐.12  ‐3.12  3.13  ‐.11  ‐2.06  3.69  ‐.06 
Medication‐related 
concerns        ‐2.96  3.15  ‐.11  ‐2.19  3.26  ‐.08  ‐.60  3.15  ‐.02  3.64  3.46  .13 
Medication‐related 
experiential feedback              3.31  3.67  .11  2.50  3.50  .08  4.89  3.79  .16 
Medication‐taking habit 
strength                    8.81  2.94  .32**  8.57  3.06  .32** 
R2‐Change  .08  .02 .01  .10 0.09
F Change  6.51*  .71  .81  8.95** 7.83**
Note. *indicates regression coefficient is significantly different from 0 at p<0.05; **indicates p<0.01; †indicates p<0.001. 
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Table 6 
Variables Predicting Self‐Reported PA Frequency at Follow‐Up (n=133; n=126 in the final column, with control variables). 
  Model 1  Model 2  Model 3  Model 4 
Model 4 with Control 
Variables 
Variable  B  SE B  Β  B  SE B  Β  B  SE B  Β  B  SE B  Β  B  SE B  β 
Barriers to PA (T1)  ‐1.14  .25  ‐.38†  ‐.87  .29  ‐.29**  ‐.88  .30  ‐.29**  ‐.62  .29  ‐.21*  ‐.54  .28  ‐.18* 
PA‐related necessity beliefs 
(T1)        .65  .24  .23**  .69  .25  .24**  .47  .25  .16  .52  .24  .18* 
PA‐related concerns (T1)        ‐.13  .31  ‐.04  ‐.14  .31  ‐.04  ‐.02  .29  ‐.01  .11  .30  .04 
PA‐related experiential 
feedback (T1)              ‐.12  .22  ‐.05  ‐.21  .21  ‐.09  ‐.30  .20  ‐.12 
PA‐related habit strength 
(T1)                    .66  .17  .35†  .63  .16  .33† 
R2‐Change  .14  .05  .002  .09  .08 
F Change  21.03†  3.97*  .29  15.74†  14.74† 
Note. *indicates regression coefficient is significantly different from 0 at p<0.05; **indicates p<0.01; †indicates p<0.001.   
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Table 7 
Physical Activity‐Related Variables Predicting Average Daily Steps, Measured By Accelerometer (n=76; n=74 with control variables included). 
  Model 1  Model 2  Model 3  Model 4 
Model 4 with Control 
Variables 
Variable  B  SE B  Β B SE B Β B SE B  Β B SE B β B SE B β 
Barriers to PA (T1)  ‐353.8  527.5  ‐.08  847.5  620.7  .19  851.6  622.7  .19  1074.1  612.5  .24  1234.1  607.4  .27* 
PA‐related necessity beliefs 
(T1)        478.3  575.6  .10  452.5  578.4  .09  142.7  577.8  .03  46.73  567.0  .01 
PA‐related concerns (T1)      ‐1975.7 640.2 ‐.42** ‐1859.7 685.5  ‐.39** ‐1733.5 644.1 ‐.36** ‐1643.8 645.4 ‐.35* 
PA‐related experiential 
feedback (T1)              372.7  498.5  .09  245.2  487.4  .06  245.0  477.0  .06 
PA‐related habit strength 
(T1)                    759.3  331.2  .27*  672.8  329.7  .24* 
R2‐Change  .01  .13 .01  .06 .05
F Change  .45  5.32**  .56  5.26* 4.16* 
Note. *indicates regression coefficient is significantly different from 0 at p<0.05; **indicates p<0.01; †indicates p<0.001. 
